• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/11

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

11 Cards in this Set

  • Front
  • Back

Hematopoiesis

complex of sequence of events in which pluripotential stem cells first commit to either a lymphoid or myeloid lineage and then develop into terminally mature cells

What are the stages of the normal myeloid maturation

stem cell CD34 DR CD117


myeloblast CD34 DR CD117 CD13 CD33


promyelocyte CD13 CD33 CD117


myelocyte CD13 CD33


metamyelocyte CD13 CD33


band CD13 CD33


neutrophil CD13 maybe CD33

How does malignancy occur

an unknown complex of sequence of events in which an abnormal stem cell proliferates forming a mutant cell that has the full capability of survival with or without the ability of differentian or maturation

Clonal disease

clone has a common genetic abnormality but may have variable cytomorph and immunophenotypic features

Acute myeloid leukemia

myeloblast is the precursor where mutation occurs



arrest in the blast stage then need other mutations to trigger proliferation



mutation can arise in different stages before mautration

chronic myelogenous leukemia

philadelphia chromosome resulting in tyrosine kinase oncogene being activated and results in major differences in the number of granulocytes

How do we dx malignant cells

cytomorph, and histomorph



cytogenetis and molecular diagnostics for dx

Cytogenetics

freeze dividing cells in metaphase and stain with geisma stain in which dark bands are those that take up A/T region

FISH

fresh or formalin fixed cells in metaphase or interphase



use a molecular probe for a specific gene region

What are some of the genetic abnormalities of hematologic malignancies

loss or gain of whole or segment chromosomes



rearrangments of the genetic material resulting in structural chromsomal changes,



fusion/translocated genes resulting in functional or biological pathway changes



point muts; resulting in dysfunctional or hyperactive uncontrollable proteins

What are the genetic abnormalities seen in AML

cytogenetic abnormalities detected at diagnosis represent the most relevant prognostic factors affecting survival



POOR OUTCOME t9;11 p22;q23


t(6;9) (p23;q34)